Clinical use of D-dimer in patients with cancer;Aplicabilidad clínica de la determinación de dímero-D en pacientes con cáncer

Medicina Clinica

Volumn 137, Issue 10, 2011, Pages 453-458

  Lecumberri, Ramón ^a   Pegenaute, Carlota ^a   Páramo, José A ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Cancer; D dimer; Haemostasis; Prognosis; Venous thromboembolism

Indexed keywords

D DIMER;

CANCER PATIENT; EVIDENCE BASED MEDICINE; HUMAN; NEOPLASM; REVIEW;

ALGORITHMS; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; DISSEMINATED INTRAVASCULAR COAGULATION; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; NEOPLASMS, UNKNOWN PRIMARY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY EMBOLISM; SENSITIVITY AND SPECIFICITY; THROMBOPHILIA; TUMOR MARKERS, BIOLOGICAL; VENOUS THROMBOSIS;

EID: 80053341828     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.07.018     Document Type: Review

References (55)

1. A. Trousseau Phlegmasia alba dolens A. Trousseau, Clinique medicale de l'Hotel-Dieu de Paris 1865 Baillire Paris 654 712
2. A. Varki Trousseaus's syndrome: multiple definitions and multiple mechanisms Blood. 110 2007 1723 1729 (Pubitemid 47443881)
3. R. Lecumberri, and E. Rocha Cáncer y tromboembolia venosa: una antigua asociación con nuevos escenarios Med Clin (Barc). 133 2009 545 546
4. H.T. Sorensen, L. Mellemkjaer, J.H. Olsen, and J.A. Baron Prognosis of cancer associated with venous thromboembolism N Engl J Med. 343 2000 1846 1850 (Pubitemid 32104130)
5. S.S. Adam, N.S. Key, and C.S. Greenberg D-dimer antigen: current concepts and future prospects Blood. 113 2009 2878 2887
6. C.E. Dempfle, S. Zips, H. Ergul, D.L. Heene Fibrin Assay Comparative Trial Study Group The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators FACT Study Group. Thromb Haemost. 85 2001 618 671
7. P.S. Wells, J. Hirsh, D.R. Anderson, A.W.A. Lensing, G. Foster, and C. Kearon Accuracy of clinical assessment of deep vein thrombosis Lancet. 345 1995 1326 1330
8. P.S. Wells, D.R. Anderson, M.R. Rodger, M. Forgie, C. Kearon, and J.F. Dreyer Evaluation of d-dimer in the diagnosis of suspected deep-vein thrombosis N Engl J Med. 349 2003 1227 1235 (Pubitemid 37152032)
9. P.D. Stein, R.D. Hull, K.C. Patel, R.E. Olson, W.A. Ghali, and R. Brant D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism Ann Intern Med. 140 2004 589 602
10. G. Le Gal, M. Righini, P.M. Roy, O. Sanchez, D. Aujesky, and H. Bounameaux Prediction of pulmonary embolism in the emergency department: the revised Geneva score Ann Intern Med. 144 2006 165 171 (Pubitemid 46780688)
11. M. Di Nisio, A.W.S. Rutjes, and H.R. Büller Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis J Thromb Haemost. 4 2006 52 57
12. M. Carrier, A.Y. Lee, S.M. Bates, D.R. Anderson, and P.S. Wells Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients Thromb Res. 123 2008 177 1783
13. M.T. Stender, J.B. Frokjaer, T.S. Hagedorn Nielsen, T.B. Larsen, S. Lundbye-Christensen, and H. Elbrond Combined use of clinical pre-test probability and D-dimer test in the diagnosis of preoperative deep venous thrombosis in colorectal cancer patients Thromb Haemost. 99 2008 396 400 (Pubitemid 351230972)
14. M. Di Nisio, M. Sohne, P.W. Kamphuisen, and H.R. Büller D-dimer test in cancer patients with suspected acute pulmonary embolism J Thromb Haemost. 3 2005 1239 1242 (Pubitemid 41725248)
15. M. Righini, G. Le Gal, S. De Lucia, P.M. Roy, G. Meyer, and D. Aujesky Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism Thromb Haemost. 95 2006 715 719
16. M. Sohne, M.J. Kruip, M. Nijkeuter, L. Tick, H. Kwakkel, and J.M. Halkes Accuracy of clinical decision rule, D-dimer and spiral computed tomography in patients with malignancy, previous venous thromboembolism, COPD or heart failure and in older patients with suspected pulmonary embolism J Thromb Haemost. 4 2006 1042 1046
17. V. King, A.A. Vaze, C.C. Moskowitz, L.J. Smith, and M.S. Ginsberg D-dimer assay to exclude pulmonary embolism in high-risk oncologic population: correlation with CT pulmonary angiography in an urgent care setting Radiology. 247 2008 854 861
18. J.A. Heit, W.M. O'Fallon, T.M. Petterson, C.M. Lohse, M.D. Silverstein, and D.N. Mohr Relative impact of risk factores for deep vein thrombosis and pulmonary embolism: a population-based study Arch Intern Med. 162 2002 1245 1248 (Pubitemid 34595030)
19. P. Prandoni, A. Falanga, and A. Piccioli Cancer and venous thromboembolism Lancet. Oncol. 6 2005 401 410 (Pubitemid 40753746)
20. G.C. Connolly, and A.A. Khorana Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score Thomb Res. 125 Suppl. 2 2010 S1 S7
21. M. Monreal, C. Falgá, M. Valdés, C. Suárez, F. Gabriel, and C. Tolosa Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry J Thromb Haemost. 4 2006 1950 1956
22. G.H. Lyman, A.A. Khorana, A. Falanga, D. Clarke-Pearson, C. Flowers, and M. Jahanzeb American Society of Clinical Oncology Guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer J Clin Oncol. 25 2007 5490 5505 (Pubitemid 350232226)
23. A.A. Khorana, N.M. Kuderer, E. Culakova, G.H. Lyman, and C.V. Francis Development and validation of a predictive model for chemotherapy-associated thrombosis Blood. 111 2008 4902 4907
24. C. Ay, R. Vormittag, D. Dunkler, R. Simanek, A.L. Chiriac, and J. Drach D-dimer and prothrombin fragment 1+2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study J Clin Oncol. 27 2009 4124 4129
25. G. Arpaia, M. Carpenedo, M. Verga, O. Mastrogiacomo, D. Fagnani, and M. Lanfredini D-dimer before chemotherapy might predict venous thromboembolism Blood. Coagul Fibrinolysis 20 2009 170 175
26. S. Mochizuki, T. Yoshino, T. Kojima, N. Fuse, H. Ikematsu, and K. Minashi Therapeutic significance of a D-dimer cut-off level of >3microg/mL in colorectal cancer patients treated with standard chemotherapy plus bevacizumab Jpn J Clin Oncol 40 2010 933 937
27. M.T. Stender, J.B. Frokjaer, T.B. Larsen, S. Lundbye-Christensen, and O. Thorlacius-Ussing Preoperative plasma D-dimer is a predictor of postoperative deep venous thrombosis in colorectal cancer patients: a clinical, prospective cohort study with one-year follow-up Dis Colon Rectum. 52 2009 446 451
28. E. Grau, M.J. Tenías, M.J. Soto, M.R. Gutiérrez, R. Lecumberri, and J.L. Pérez D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry Crit Care Med. 35 2007 1937 1941 (Pubitemid 47220369)
29. G. Palareti, B. Cosmi, C. Legnani, A. Tosetto, C. Brusi, and A. Iorio D-Dimer testing to determine the duration of anticoagulation therapy N Engl J Med. 355 2006 1780 1789 (Pubitemid 44631361)
30. C. Kearon, S. Kahn, G. Agnelli, S. Goldhaber, G.E. Raskob, and A.J. Comerota Antithrombotic therapy for venous thromboembolic disease. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed Chest. 133 2008 454S 545S (Pubitemid 351892971)
31. J. Trujillo-Santos, J.A. Nieto, A. Ruíz-Gamietea, L. López-Jiménez, F. García-Bragado, and R. Quintanavalla Bleeding complications associated with anticoagulant therapy in patients with cancer Thromb Res. 125 Suppl 2 2010 S58 S61
32. B. Cosmi, C. Legnani, M. Cini, G. Guazzaloca, and G. Palareti The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients Haematologica. 90 2005 713 715 (Pubitemid 40780904)
33. J.D. Douketis, C. Gu, A. Piccioli, A. Ghirarduzzi, V. Pengo, and P. Prandoni The long-term risk of cancer in patients with a first episode of venous thromboembolism J Thromb Haemost. 7 2009 546 551
34. M. Monreal, A.W. Lensing, M.H. Prins, M. Bonet, J. Fernández- Llamazares, and J. Muchart Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism J Thromb Haemost. 2 2004 876 881 (Pubitemid 40185732)
35. A.Y. Lee Screening for occult cancer in patients with idiopathic venous thromboembolism: no J Thromb Haemost. 1 2003 2273 2274
36. A. Piccioli, and P. Prandoni Screening for occult cancer in patients with idiopathic venous thromboembolism: yes J Thromb Haemost. 1 2003 2271 2272
37. A. Piccioli, A.W. Lensing, M.H. Prins, A. Falanga, G.L. Scannapieco, and M. Ieran Extensive screening for occult malignat disease in idiopathic venous thromboembolism: a prospective randomized clinical trial J Thromb Haemost. 2 2004 884 889 (Pubitemid 40185734)
38. R.E. Schutgens, M.M. Beckers, F.J. Haas, and D.H. Biesma The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis Haematologica. 90 2005 214 219
39. S. Paneesha, E. Cheyne, K. French, S. Bacchu, A. Borg, and P. Rose High D-dimer levels at presentation in patients with venous thrombosis is a marker of adverse clinical outcomes Br J Haematol. 135 2006 85 90 (Pubitemid 44337667)
40. B. Cosmi, C. Legnani, A. Tosetto, V. Pengo, A. Ghirarduzzi, and A. Alatri Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG study J Thromb Thrombolysis. 28 2009 381 388
41. J.A. Páramo Coagulación intravascular diseminada Med Clin (Barc). 127 2006 785 789
42. J.B. Taylor Jr., C.H. Toh, W.K. Hoots, H. Wada, and M. Levi Towards definition, clinical and laboratory criteria and a scoring system for disseminated intravascular coagulation on behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis Thromb Haemost 86 2001 1327 1330 (Pubitemid 33064585)
43. C.H. Toh, W.K. Hoots on behalf of the SSC on Disseminated Intravascular Coagulation of the ISTH The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview J Thromb Haemost. 5 2007 604 606 (Pubitemid 46680696)
44. C.E. Dempfle, M. Wurst, M. Smolinski, S. Lorenz, A. Osika, and D. Olenik use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score Thromb Haemost. 91 2004 812 818 (Pubitemid 38477464)
45. H.C. Kwon, S.Y. Oh, S. Lee, S.H. Kim, J.Y. Han, and R.Y. Koh Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients Jpn J Clin Oncol. 38 2008 2 7 (Pubitemid 351248114)
46. Y. Tomimaru, M. Yano, K. Takachi, K. Kishi, I. Miyashiro, and M. Ohue Plasma D-dimer levels show correlation with number of lymph node metastases in patients with esophageal cancer J Am Coll Surg. 202 2006 139 145 (Pubitemid 43000354)
47. I. Gil-Bazo, J.A. Páramo, and J. García-Foncillas Nuevos marcadores pronósticos y predictivos en el cáncer colorrectal avanzado Med Clin (Barc). 126 2005 541 548 (Pubitemid 43759749)
48. Y. Tomimaru, M. Yano, K. Takachi, K. Kishi, I. Miyashiro, and M. Ohue Correlation between pretherapeutic d-dimer levels and response to neoadjuvant chemotherapy in patients with advanced esophageal cancer Dis Esophagu. s 21 2008 281 287 (Pubitemid 351663442)
49. M. Kilic, O. Yoldas, M. Keskek, T. Ertan, M. Tez, and E. Gocmen Prognostic value of plasma D-dimer levels in patients with colorectal cancer Colorectal Dis. 10 2008 238 241 (Pubitemid 351284674)
50. G. Altiay, A. Ciftci, M. Demir, Z. Kocak, N. Sut, and E. Tabakoglu High plasma D-dimer levels is associated with decreased survival in patients with lung cancer Clin Oncol (R Coll Radiol). 19 2007 494 498 (Pubitemid 47181178)
51. D. Antoniou, G. Pavlakou, G.P. Stathopoulos, I. Karydis, E. Chondrou, and C. Papageorgiou Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer Lung Cancer. 53 2006 205 210 (Pubitemid 43994226)
52. S.C. Koh, R. Khalil, F.K. Lim, A. Ilancheran, and M. Choolani The association between fibrinogen, von Willebrand factor, antithrombin III, and D-dimer levels and survival outcome by 36 months from ovarian cancer Clin Appl Thromb Hemost. 12 2006 3 8 (Pubitemid 43221565)
53. A.P. Batschauer, C.P. Figueiredo, E.C. Bueno, M.A. Ribeiro, L.M. Dusse, and A.P. Fernandes D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer Ann Oncol. 21 2010 1267 1272
54. R. Lecumberri, J.A. Páramo, and E. Rocha Anticoagulant treatment and survival in cancer patients. The evidence from clinical studies Haematologica. 90 2005 1258 1266 (Pubitemid 41375284)
55. M. Di Nisio, C.P.W. Klerk, J.C.M. Meijers, and H.R. Büller The prognostic value of D-dimer test in cancer patients treated with and without low-molecular-weight heparin J Thromb Haemost. 3 2005 1531 1533 (Pubitemid 41725214)